ComplianceGrowth

Demystifying the New Q14 & Q2(R2) Guidelines: A Streamlined Approach to Analytical Procedures

Meredith Crabtree
Recording Webinar Available @All Days
Recording         $249  
  

Description

This webinar will delve into the recent updates to the Q14 and Q2(R2) guidelines, providing a comprehensive understanding of their impact on analytical procedures in the pharmaceutical industry. Through interactive presentations and practical examples, attendees will gain valuable insights into:

  • The scientific and risk-based approach emphasized in the revised guidelines.
  • Developing robust and efficient analytical procedures aligned with the Analytical Target Profile.
  • Implementing a risk-based validation strategy that focuses on critical aspects.
  • Ensuring compliance with the latest regulatory requirements.

This webinar benefits the following agencies:

  • Pharmaceutical companies
  • Contract research organizations (CROs)
  • Regulatory agencies
  • Biopharmaceutical companies

Who Should Attend?

This webinar is ideal for working professionals involved in the development, validation, and implementation of analytical procedures for drugs, including:

  • Analytical chemists
  • Quality control personnel
  • Regulatory affairs specialists
  • Drug development scientists
  • Research scientists



* Or more than 6 attendee call us at +1-830-256-0384 or mail us at cs@compliancegrowth.com

* For Cheque and ACH payment call us at +1-830-256-0384 or mail us at cs@compliancegrowth.com

* Click to download the Order Form